Skip to main content
Screener/Healthcare/Drug Manufacturers - Specialty & Generic

EBS Emergent BioSolutions Inc.

NYSE
$9.49+0.36 (+4.00%)
$5.30
$14.06
$9.10
$9.64
EPS (TTM)$-0.26
P/E Ratio8.89
Dividend Yield
Market Cap$441.0M
Volume677K
Prev Close$9.13
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$156.1M$0$0.0039.2%0.0%
Q4 '25$148.7M-$54.6M$-0.9520.9%-36.7%
Q3 '25$231.1M$51.2M$0.9160.3%22.2%
Q2 '25$140.9M-$12.0M$-0.2243.1%-8.5%
Q1 '25$222.2M$68.0M$1.1953.7%30.6%
Q4 '24$194.7M-$31.3M$-0.5970.1%-16.1%
Q3 '24$293.8M$114.8M$2.0655.9%39.1%
Q2 '24$254.7M-$283.1M$-5.38-25.7%-111.2%
Get Your Daily Market Recap
EBS Stock Price, Chart & Analysis